用于蛋白质和小分子的棕化调节剂
Zeshuai Fan1, Yuchen Hao1, Yidan Huo1
1Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University, Baoding, 071002, China.
European journal of medicinal chemistry
|April 15, 2024
概括
棕化是一种关键的脂质修饰,调节细胞功能,对于治疗癌症等疾病至关重要. 本综述涵盖了其类型,酶和治疗开发的抑制剂.
科学领域:
- 生物化学和分子生物学
- 细胞和生理过程
- 药物发现和开发 药物发现和开发
背景情况:
- 棕化是一种重要的脂质修饰,调节关键的细胞功能.
- 它在各种生理过程中起着重要作用.
- 棕化失调与癌症和神经系统疾病等疾病有关.
研究的目的:
- 为了提供一个全面的概述 palmitoylation.
- 详细介绍相关的调节酶,包括棕甲基转移酶和棕甲基酶.
- 讨论当前的治疗策略,专注于可用的抑制剂.
主要方法:
- 关于棕细胞代谢现有研究的文献综述.
- 棕代谢的分类为N-,O-和S-棕代谢.
- 对调节酶及其抑制剂的分析.
主要成果:
- 棕化被分为三种不同的类型:N-棕化,O-棕化和S-棕化.
- 调节棕结合的关键酶包括棕结合转移酶和棕结合酶.
- 已经确定了一系列针对这些酶的广泛和选择性抑制剂.
结论:
- 棕化是一种重要的细胞过程,对各种疾病具有治疗潜力.
- 了解棕化酶和抑制剂对于开发向疗法至关重要.
- 对选择性抑制剂的进一步研究可能会导致癌症和神经系统疾病的新治疗方法.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Lipids as Anchors
5.6K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.6K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Regulation of Metabolism
9.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.4K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K


